Published in Medicine (Baltimore) on July 01, 1992
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc Natl Acad Sci U S A (2012) 1.24
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother (1998) 1.09
Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infect Immun (2002) 0.97
Seizure as an initial presentation of human immunodeficiency virus: acute toxoplasmosis mimicking glioblastoma multiforme. BMJ Case Rep (2013) 0.91
Challenges in diagnosis, treatment and follow-up of patients presenting with central nervous system infections in a resource-limited setting. Mcgill J Med (2006) 0.89
Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy. J Neurol Neurosurg Psychiatry (1998) 0.81
Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia. PLoS Negl Trop Dis (2013) 0.79
Brain biopsy in AIDS patients: diagnostic yield and treatment applications. AIDS Res Ther (2014) 0.77
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis. Pathog Glob Health (2017) 0.76
Retracted Toxoplasmosis - An update. Trop Parasitol (2011) 0.76
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med (1993) 3.75
Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet (1999) 3.43
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Phacoemulsification in eyes with past pars plana vitrectomy: case-control study. J Cataract Refract Surg (1999) 3.26
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis (1987) 2.71
Determining the common medical presenting problems to an accident and emergency department. Arch Dis Child (2001) 2.67
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J Clin Microbiol (1995) 2.41
The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology (1995) 2.41
Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1993) 2.35
16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene. J Clin Microbiol (1998) 2.33
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Two different 16S rRNA genes in a mycobacterial strain. J Clin Microbiol (1996) 2.17
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med (1994) 2.16
Cloning and analysis of the K1 capsule biosynthesis genes of Escherichia coli: lack of homology with Neisseria meningitidis group B DNA sequences. Infect Immun (1983) 2.15
Structure of human cystathionine beta-synthase: a unique pyridoxal 5'-phosphate-dependent heme protein. EMBO J (2001) 2.12
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med (1991) 2.10
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet (2006) 2.09
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med (2008) 2.03
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. Ann Intern Med (1991) 2.02
[HIV epidemic: an end to exceptional regulation? Response to the article which appeared under this title in the Revue médicale de la Suisse romande (112, 239-241, 1991)]. Rev Med Suisse Romande (1992) 2.02
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology (1994) 2.01
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol (2007) 1.98
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med (1995) 1.95
Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis (2001) 1.89
Mycobacterium genavense sp. nov. Int J Syst Bacteriol (1993) 1.88
Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke (1996) 1.84
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (2003) 1.76
Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med (1982) 1.75
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis (1998) 1.72
A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med (1990) 1.71
Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol (1983) 1.71
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology (1997) 1.70
Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J Clin Microbiol (1996) 1.67
Red fingers syndrome in patients with HIV and hepatitis C infection. Lancet (1996) 1.66
Predictive factors for endothelial cell loss after penetrating keratoplasty. Arch Ophthalmol (1993) 1.66
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol (1998) 1.65
Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.65
Emergence delirium in a child given oral midazolam for conscious sedation. Ann Emerg Med (1994) 1.63
Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology (1997) 1.62
Wilson's disease: presymptomatic patients and Kayser-Fleischer rings. Ophthalmic Genet (1997) 1.58
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS (1994) 1.55
Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy. AIDS (2001) 1.55
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS (1992) 1.55
Corneal toxicity from hydrogen peroxide-soaked tonometer tips. Case report. Arch Ophthalmol (1988) 1.55
Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med (2011) 1.55
Who should receive mitomycin-C after pterygium surgery? Ophthalmology (1992) 1.53
Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis (1993) 1.52
Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort Study. AIDS (1996) 1.52
Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis (1990) 1.50
Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol (1996) 1.47
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS (1998) 1.46
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis (1999) 1.46
High-resolution and functional magnetic resonance imaging of the brachial plexus using an isotropic 3D T2 STIR (Short Term Inversion Recovery) SPACE sequence and diffusion tensor imaging. Eur Radiol (2008) 1.46
Needle muscle biopsy in the investigation of neuromuscular disorders. Muscle Nerve (1998) 1.45
Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology (2001) 1.44
The dental management of patients with natural rubber latex allergy. Br Dent J (1998) 1.44
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. AIDS (2000) 1.44
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study. AIDS (1999) 1.44
Small, overlapping tectonic keratoplasty involving graft-host junction of penetrating keratoplasty. Am J Ophthalmol (2000) 1.41
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure]. Schweiz Med Wochenschr (1999) 1.40
Outcome of cornea, iris, and lens perforation during automated lamellar keratectomy. Arch Ophthalmol (1996) 1.40
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med (2006) 1.38
Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey. J Clin Microbiol (1996) 1.38
Sexual transmission during the incubation period of primary HIV infection. JAMA (2001) 1.37
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther (2010) 1.36
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med (1997) 1.35
Ignition and explosion risks of nanopowders. J Hazard Mater (2010) 1.34